Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,492.00 INR | +0.41% | +5.43% | +83.89% |
Nov. 28 | NATCO Pharma Sells Land in Telangana, India for INR1.16 Billion | MT |
Nov. 21 | NATCO Pharma Limited Announces Submission of Abbreviated New Drug Application for Risdiplam for Oral Solution | CI |
Chart calendar NATCO Pharma Limited
Upcoming events on NATCO Pharma Limited
Past events on NATCO Pharma Limited
2024-11-13 12:30 am | Q2 2025 Earnings Call |
2024-11-12 04:00 am | Q2 2025 Earnings Release |
2024-09-30 01:30 am | Annual General Meeting |
2024-09-19 | Investor Meeting - Nuvama Wealth Management |
2024-09-18 | Investor Meeting - UJLK Financial Services |
2024-09-10 | Citi Healthcare Tour |
2024-09-04 | Ashwamedh Elara India Dialogue Conference |
2024-09-02 06:00 am | Investor Meeting |
2024-08-14 04:30 am | Emkay Confluence India Conference |
2024-08-13 01:30 am | Q1 2025 Earnings Call |
2024-08-12 04:30 am | Q1 2025 Earnings Release |
2024-07-04 12:30 am | Investor Meeting - ICICI Securities |
2024-06-10 06:00 am | Investor Meeting - J M Financial |
2024-05-29 | B&K Securities Trinity Investor Conference |
2024-05-29 01:30 am | Investor Meeting - ICICI Securities |
2024-05-28 01:30 am | Q4 2024 Earnings Call |
2024-05-27 07:12 am | Q4 2024 Earnings Release |
2024-04-22 02:30 am | Investor Meeting - HSBC Global |
2024-03-06 01:30 am | Investor Meeting - ICICI Securities |
2024-02-27 10:30 pm | Investec Promoter & Founder Conference |
Past dividends on NATCO Pharma Limited
2024-11-26 | Interim Payment 1.5 INR |
2024-08-22 | Interim Payment 3 INR |
2024-02-25 | Interim Payment 1.25 INR |
2023-11-23 | Interim Payment 1.25 INR |
2023-08-21 | Interim Payment 7 INR |
2023-02-20 | Interim Payment 1.25 INR |
2022-11-20 | Interim Payment 0.75 INR |
2022-08-18 | Interim Payment 3.5 INR |
2022-02-23 | Interim Payment 2 INR |
2021-11-22 | Interim Payment 0.5 INR |
2021-08-23 | Interim Payment 2 INR |
2021-02-21 | Interim Payment 1 INR |
2020-11-23 | Interim Payment 3 INR |
2020-08-20 | Interim Payment 1.25 INR |
2020-06-25 | Interim Payment 1 INR |
2020-02-23 | Interim Payment 3.5 INR |
2019-11-20 | Interim Payment 1 INR |
2019-08-21 | Interim Payment 1.25 INR |
2019-06-05 | Interim Payment 1.25 INR |
2019-02-20 | Interim Payment 3.5 INR |
Annual results
Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 19 448 19 848 -2.02% | 27 071 26 844 0.85% | 39 988 39 185 2.05% | 50 546 | 55 674 | 37 151 |
EBITDA Million INR | Released Forecast Spread | 2 635 5 360 -50.84% | 9 356 9 761 -4.15% | 17 514 16 899 3.64% | 26 547 | 26 663 | 10 016 |
EBIT Million INR | Released Forecast Spread | 1 209 4 105 -70.55% | 7 718 8 088 -4.57% | 15 646 15 221 2.79% | 24 895 | 25 232 | 8 303 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 2 022 5 124 -60.54% | 8 619 9 068 -4.96% | 16 735 16 001 4.59% | 26 383 | 26 962 | 11 147 |
Net income Million INR | Released Forecast Spread | 1 700 3 978 -57.26% | 7 153 7 188 -0.49% | 13 883 13 212 5.08% | 21 570 | 21 668 | 8 965 |
EPS INR | Released Forecast Spread | 9,32 21,9 -57.44% | 39,2 39,5 -0.77% | 77,3 73,2 5.61% | 121 | 121 | 52,4 |
Announcement Date | 30/05/22 | 29/05/23 | 27/05/24 | - |
Quarterly results
Fiscal Period | March | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 4 321 6 309 -31.51% | 4 925 5 421 -9.14% | 8 979 8 321 7.91% | 11 405 11 402 0.02% | 10 314 10 790 -4.41% | 7 586 5 742 32.11% | 10 683 9 922 7.67% | 13 626 13 345 2.11% | 13 176 | 5 416 | 14 355 |
EBITDA Million INR | Released Forecast Spread | 953 2 034 -53.14% | 1 059 1 322 -19.91% | 3 391 3 606 -5.95% | 5 280 5 247 0.63% | 4 580 4 930 -7.1% | 2 681 1 284 108.83% | 4 973 4 376 13.64% | 8 048 6 826 17.91% | 7 015 | 542 | 8 001 |
EBIT Million INR | Released Forecast Spread | 2 239 692 223.55% | 4 418 3 504 26.08% | 7 607 9 664 -21.29% | 7 095 | 30,0 | 7 490 | |||||
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 814 833 -2.28% | 3 244 1 583 104.93% | 5 000 4 273 17.01% | 4 396 4 672 -5.91% | 4 776 4 732 0.93% | 8 036 5 878 36.71% | 7 534 | 468 | 7 928 | ||
Net income Million INR | Released Forecast Spread | 568 1 385 -59% | 623 942 -33.87% | 2 758 2 596 6.22% | 4 203 3 957 6.22% | 3 690 5 355 -31.1% | 2 127 833 155.29% | 3 863 3 241 19.19% | 6 685 5 504 21.46% | 5 639 | 351 | 5 946 |
EPS INR | Released Forecast Spread | 3,11 5,10 -39.02% | 3,41 3,90 -12.56% | 15,1 6,80 122.21% | 23,3 19,0 22.42% | 20,6 21,4 -3.85% | 11,9 3,68 222.83% | 21,6 15,0 43.73% | 37,3 42,0 -11.14% | 31,5 | 1,90 | 32,2 |
Announcement Date | 10/11/22 | 09/02/23 | 29/05/23 | 09/08/23 | 14/11/23 | 14/02/24 | 27/05/24 | 12/08/24 | - | - | - |
Past sector events for NATCO Pharma Limited
2024-12-08 07:01 pm | BORA PHARMACEUTICALS CO., LTD.: November 2024 Sales and Revenue Release |
2024-12-04 02:06 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: November 2024 Sales and Revenue Release |
2024-11-28 | DOTTIKON ES HOLDING AG: Q2 2025 Earnings Release |
2024-11-15 01:38 am | BAVARIAN NORDIC A/S: Q3 2024 Earnings Release |
2024-11-14 11:01 pm | CSPC PHARMACEUTICAL GROUP LTD.: Q3 2024 Earnings Release |
2024-11-14 09:03 am | GUFIC BIOSCIENCES LIMITED: Q2 2025 Earnings Release |
2024-11-14 07:00 am | OCULAR THERAPEUTIX, INC.: Q3 2024 Earnings Release |
2024-11-14 02:49 am | IPCA LABORATORIES LIMITED: Q2 2025 Earnings Release |
2024-11-14 01:30 am | DERMAPHARM HOLDING SE: Q3 2024 Earnings Release |
2024-11-14 01:30 am | ALK-ABELLÓ A/S: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NATCOPHARM Stock
- Calendar NATCO Pharma Limited